Medicare Enrolled

Dr. Rodolfo Amaro-Galvez, MD

Pulmonary Disease · Tyler, TX
Low-engagement
11937 US HIGHWAY 271, Tyler, TX 75708
9038777072
In practice since 2005 (20 years)
NPI: 1023006509 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amaro-Galvez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amaro-Galvez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amaro-Galvez

Dr. Rodolfo Amaro-Galvez is a pulmonary disease in Tyler, TX, with 20 years in practice.

Between the years covered by Open Payments, Dr. Amaro-Galvez received a total of $2,961 from 28 pharmaceutical and/or device companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amaro-Galvez is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $2,961 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,961
Total received (2018-2024)
Avg $423/year across 7 years
Top 43% in TX for pulmonary disease
28
Companies
111
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,961 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$517
2023
$329
2022
$866
2021
$365
2020
$56
2019
$526
2018
$302

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$342
Chiesi USA, Inc.
$299
VERTEX PHARMACEUTICALS INCORPORATED
$264
GENZYME CORPORATION
$254
Vertex Pharmaceuticals Incorporated
$205
ABBVIE INC.
$201
JAZZ PHARMACEUTICALS INC.
$192
Philips Electronics North America Corporation
$171
AbbVie Inc.
$145
Regeneron Healthcare Solutions, Inc.
$133
GlaxoSmithKline, LLC.
$73
Shire North American Group Inc
$72
Gilead Sciences, Inc.
$68
Genentech USA, Inc.
$62
Mylan Specialty L.P.
$54
Teva Pharmaceuticals USA, Inc.
$52
AIMMUNE THERAPEUTICS, INC.
$46
Baxter Healthcare
$46
Electromed, Inc.
$44
ALCRESTA THERAPEUTICS, INC.
$43
SANOFI-AVENTIS U.S. LLC
$43
Advanced Respiratory, Inc
$37
VIVUS LLC
$23
Nestle HealthCare Nutrition Inc.
$23
Paratek Pharmaceuticals, Inc.
$19
ACADIA Pharmaceuticals Inc
$19
Alcresta Therapeutics, Inc.
$17
Inspire Medical Systems, Inc.
$17
Top 3 companies account for 30.5% of total payments
Associated products mentioned in payments ›
(8874) inCourage · AirDuo Digihaler · BRONCHITOL · CINRYZE · CREON · Cayston · DAYBUE · DUPIXENT · FASENRA · Hillrom - Vest System Model 105 Home Care · INSPIRE · NUCALA · NUZYRA · ORKAMBI · PERTZYE · ProAir Digihaler · Pulmozyme · QSYMIA · RELIZORB · Respiratoriy Care Undiv · SMARTVEST · SOTROVIMAB · TEZSPIRE · TOBI PODHALER · TRIKAFTA · The MetaNeb System · The Vest System Model 105 Home Care · Tobi Podhaler · Wellcentive Undiv · XYREM · ZENPEP · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease in Tyler?
Compare pulmonary diseases in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
12
Per 100K population
5.0
County median income
$71,923
Nearest hospital
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Amaro-Galvez is a pulmonary disease, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Amaro-Galvez receive payments from pharmaceutical companies?
Yes. Dr. Amaro-Galvez received a total of $2,961 from 28 companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Amaro-Galvez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Tyler
Browse pulmonary diseases in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Chiesi USA, Inc. Payments to Doctors
See all physicians who received payments from Chiesi USA, Inc..
By company
VERTEX PHARMACEUTICALS INCORPORATED Payments to Doctors
See all physicians who received payments from VERTEX PHARMACEUTICALS INCORPORATED.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →